File:Euler's_formula.svg · Wikimedia Commons · See Wikimedia Commons
half-life
Sign in to saveAlso known as half life, half-life period
{| class="wikitable" align=right ! Half-liveselapsed !! Fractionremaining !! colspan=2| Percentageremaining |- | 0 || ||align=right style="border-right-width: 0; padding-right:0"| 100||style="border-left-width: 0"| |- | 1 || ||align=right style="border-right-width: 0; padding-right:0"| 50||style="border-left-width: 0"| |- | 2 || ||align=right style="border-right-width: 0; padding-right:0"| 25||style="border-left-width: 0"| |- | 3 || ||align=right style="padding-right:0; border-right-width: 0"| 12||style="border-left-width: 0; padding-left:0"|.5 |- | 4 || ||align=right style="border-right-width
Half-life is the amount of time it takes for half of a radioactive substance to decay or break down. This concept matters because it allows scientists to predict how quickly radioactive materials will diminish over time and to determine the age of ancient objects.
AI-generated from the Wikipedia summary — may contain errors.
Research
157,545 papers- Relevance of Half-Life in Drug Design.Journal of medicinal chemistry · 2018Smith DA, Beaumont K, Maurer TS et al.DOI: 10.1021/acs.jmedchem.7b00969
- The αSynuclein half-life conundrum.ReviewNeurobiology of disease · 2024Masato A, Bubacco LDOI: 10.1016/j.nbd.2024.106524
- The Practical Importance of Half-Life in Psychopharmacology.The Journal of clinical psychiatry · 2022Andrade CDOI: 10.4088/JCP.22f14584
- Half-life extended biotherapeutics.ReviewExpert opinion on biological therapy · 2016Kontermann REDOI: 10.1517/14712598.2016.1165661
- Enhanced antibody half-life improves in vivo activity.Nature biotechnology · 2010Zalevsky J, Chamberlain AK, Horton HM et al.DOI: 10.1038/nbt.1601
- Half-life extension of therapeutics: Applications and mechanisms.ReviewThe Journal of pharmacology and experimental therapeutics · 2025Pathivada K, Glassman PMDOI: 10.1016/j.jpet.2025.103724
- Plasma terminal half-life.ReviewJournal of veterinary pharmacology and therapeutics · 2004Toutain PL, Bousquet-Mélou ADOI: 10.1111/j.1365-2885.2004.00600.x
- A long-half-life, high-affinity P-selectin inhibitor.Blood · 2021Gross PLDOI: 10.1182/blood.2021012302
via PubMed
Wikidata facts
- Image
- Halflife-sim.gif
Show 1 more fact
- Commons category
- Half times
Sources (2)
via Wikidata · CC0
~11 min read
Article
13 sectionsContents
- Probabilistic nature
- Formulas for half-life in exponential decay
- Half-life and reaction orders
- Zero order kinetics
- First order kinetics
- Second order kinetics
- Decay by two or more processes
- Examples
- In non-exponential decay
- In biology and pharmacology
- See also
- References
- External links
{| class="wikitable" align=right ! Half-liveselapsed !! Fractionremaining !! colspan=2| Percentageremaining |- | 0 || ||align=right style="border-right-width: 0; padding-right:0"| 100||style="border-left-width: 0"| |- | 1 || ||align=right style="border-right-width: 0; padding-right:0"| 50||style="border-left-width: 0"| |- | 2 || ||align=right style="border-right-width: 0; padding-right:0"| 25||style="border-left-width: 0"| |- | 3 || ||align=right style="padding-right:0; border-right-width: 0"| 12||style="border-left-width: 0; padding-left:0"|.5 |- | 4 || ||align=right style="border-right-width: 0; padding-right:0"| 6||style="border-left-width: 0; padding-left:0"|.25 |- | 5 || || align=right style="border-right-width: 0; padding-right:0"|3||style="border-left-width: 0; padding-left:0"|.125 |- | 6 || || align=right style="border-right-width: 0; padding-right:0"|1||style="border-left-width: 0; padding-left:0"|.5625 |- | 7 || ||align=right style="border-right-width: 0; padding-right:0"| 0||style="border-left-width: 0; padding-left:0"|.78125 |-
|- | || || colspan=2| |}
Gallery (4)
Available in 83 languages
- Español
- Français
- Deutsch
- 中文
- 日本語
- Русский
- Português
- Italiano
- العربية
- हिन्दी
- Afrikaans
- Aragonese
- Asturian
- Azerbaijani
- Bahasa Indonesia
- Bangla
- Basque
- Belarusian
Show 64 more
- Bhojpuri
- Bosnian
- Bulgarian
- Burmese
- Catalan
- Central Kurdish
- Chuvash
- Croatian
- Czech
- Danish
- Esperanto
- Estonian
- Finnish
- Galician
- Gan Chinese
- Georgian
- Greek
- Haitian Creole
- Hebrew
- Hungarian
- Icelandic
- Irish
- Kannada
- Kazakh
- Latvian
- Limburgish
- Lithuanian
- Low German
- Macedonian
- Malay
- Malayalam
- Mongolian
- Moroccan Arabic
- Nederlands
- Northern Frisian
- Norwegian
- Norwegian Nynorsk
- Occitan
- Polski
- Quechua
- Romanian
- Serbian
- Serbian (Latin)
- simple
- Slovak
- Slovenian
- Svenska
- Swahili
- Tamil
- Tatar
- Telugu
- Tiếng Việt
- Türkçe
- Ukrainian
- Urdu
- Uzbek
- Welsh
- Western Panjabi
- Wu Chinese
- zh_min_nan
- zh_yue
- فارسی
- ไทย
- 한국어
via Wikidata sitelinks · CC0